Showing 1-10 of 333 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| Addressing and mitigating sources of variability for the controlled and automated manufacturing of stem cell-derived beta (SC-beta) cells from pluripotent stem cells (PSCs) | Advanced Regenerative Manufacturing Institute (ARMI) | Thomas Bollenbach | Cures | 01-January-2023 to 31-December-2026 | $1,241,255.20 |
| Repurposing Cardiorenal Drugs for T1D: Building Evidence from Existing Trials (ReCaRD T1D) | AdventHealth | Richard Pratley | Improving Lives | 01-September-2023 to 31-August-2025 | $110,840.00 |
| Telemedicine-Delivered Unified Protocol for Cognitive Behavioral Therapy for Anxiety and Depression in Young Adults with Type 1 Diabetes | Albert Einstein College of Medicine | Jeffrey Gonzalez | Improving Lives | 01-December-2022 to 30-November-2026 | $1,672,180.00 |
| Telemedicine-Delivered Cognitive Behavioral Therapy to Reduce Diabetes Distress in Young Adults with Type 1 Diabetes (CBT-DD) | Albert Einstein College of Medicine | Jeffrey Gonzalez | Improving Lives | 01-September-2021 to 01-July-2027 | $1,484,824.00 |
| Evaluating the Initial Efficacy, Acceptability, and Feasibility of BFST-DT, an Intervention for Improving Transition Readiness for Adolescents and Emerging Adults with Type 1 Diabetes | Ann & Robert H. Lurie Children’s Hospital of Chicago | Jaclyn Papadakis | Improving Lives | 01-May-2023 to 30-April-2027 | $396,471.68 |
| A hybrid effectiveness implementation trial of an intervention to reduce diabetes-specific emotional distress. | Ann & Robert H. Lurie Children’s Hospital of Chicago | Jill Weissberg-Benchell | Improving Lives | 01-September-2024 to 31-August-2029 | $1,936,551.00 |
| Risk and Protective Factors for Optimal Health Outcomes in Children with Type 1 Diabetes (T1D) and their Parents | Ann & Robert H. Lurie Children’s Hospital of Chicago | Jillian Merrick | Transportfolio | 01-September-2023 to 31-August-2025 | $129,046.51 |
| Oxygen Enabled High-capacity Vascularized Devices for ß-cell Replacement Therapy in Humans | Arizona Board of Regents, University of Arizona | Klearchos Papas | Cures | 01-September-2023 to 31-August-2026 | $2,652,490.70 |
| Avera eCare School Health T1D Demonstration Project | Avera McKennan | Christine Hockett | Improving Lives | 01-November-2021 to 31-July-2025 | $4,000,979.73 |
| Understanding Disease Mechanisms Underlying Type 1 Diabetes | Baylor College of Medicine | Ashok Balasubramanyam | Cures | 01-November-2024 to 31-October-2027 | $967,091.04 |